S&P 500

5.277,51

0,80%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Medite Cancer Diagnostics Inc (CE) (MDIT)
Medite Cancer Diagnostics Inc (CE) (MDIT) Notícias

MDIT

Medite Cancer Diagnostics (CE) (MDIT)

Medite Cancer Diagnostics Inc (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:MDIT

1

Data	Hora	Fonte	Título	Código	Companhia
06/05/2019	17:18	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
02/04/2019	15:39	Edgar (US Regulatory)	Amended Termination of Registration of a Class of Security Under Section 12(g) (15-12g/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
01/04/2019	17:11	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
22/03/2019	13:55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
28/02/2019	20:39	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
14/11/2018	20:20	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
07/11/2018	17:45	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
02/11/2018	18:43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
26/10/2018	07:08	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
23/10/2018	15:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
06/09/2018	12:48	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
20/07/2018	11:59	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
17/05/2018	17:39	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
14/05/2018	11:21	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
28/02/2018	18:54	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
12/02/2018	19:41	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
01/05/2017	17:52	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
22/11/2016	16:47	Edgar (US Regulatory)	Information Statements (revised) (prer14c)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
03/11/2016	13:34	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
02/09/2016	12:39	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)
08/01/2016	20:00	Edgar (US Regulatory)	Information Statement (definitive, Revised) (defr14c)	USOTC:MDIT	Medite Cancer Diagnostics Inc (CE)